Herschler Building East 2nd Floor
122 W 25th St, Cheyenne, WY 82002
Phone: (307) 634-9636 Fax: (307) 634-6335
bop@wyo.gov

Mission Statement

The mission of the Wyoming State Board of Pharmacy is to promote and protect the health and safety of the public by regulating the practice of pharmacy.

License Verification

Prescription Drug Monitoring Program

Current News & Information

Wyoming State Board of Pharmacy Proposes Revisions to Chapter 22: Compounding, of the Wyoming Pharmacy Act Rules and Regulations

The Wyoming State Board of Pharmacy (Board) proposes to amend Chapter 22: Compounding of the Wyoming Pharmacy Act Rules and Regulations in order to correct technical errors in the chapter’s incorporation by reference as recommended by the Wyoming Legislative Service Office.

As required by Wyoming Statute § 16-3-103(a)(i)(G), these rules meet minimum substantive state statutory requirements.

Chapter 22: Compounding

In accordance with W.S. § 16-3-103(h)(i), the Board expressly states that the Board has determined that incorporation of the full text of these general chapters would be cumbersome or inefficient.
In accordance with W.S. § 16-3-103(h)(ii) the Board fully identifies and clarifies the date of the incorporated matter. In addition, the Board expressly states that the incorporated chapters do not include any later amendments or editions.

Requests for copies of the proposed revisions may be addressed to the Board executive director at 122 West 25th Street, Herschler Building East 2nd Floor, Cheyenne, WY 82002. The proposed revisions are posted on the Wyoming Secretary of State and on the Wyoming State Board of Pharmacy websites. Comments may be submitted to the Board by mail using the address above or to bop@wyo.gov on or before June 5, 2026, at 5 PM MDT.

Business License and Individual Controlled Substance Renewals OPEN

Business licenses (resident pharmacies, nonresident pharmacies, wholesale distributors, business controlled substance registrations, etc.) expire annually on June 30th. Individual control substance registrations expire every other year on June 30th. Renewals are now open. Renewal forms and renewal instructions are available on the Board’s website. At this time, we ask that all third party logistics providers (3PLs) and Wyoming pharmacies submit their 2026-2027 renewal via paper renewal application to the Board office. Please note:

• Resident pharmacies that hold a resident retail license, an institutional license, and a business-controlled substance registration only need to submit one (1) business-controlled substance registration renewal fee.

• We do not verify the receipt of renewal applications due to heavy volume; and

• We cannot accept renewal applications that are submitted via fax or email.

New June Regular Board Meeting

On April 13, 2026, the Wyoming State Board of Pharmacy met and selected a different date for its regular June Meeting. The Board will now meet on June 16/17, 2026.

The Wyoming State Board of Pharmacy office has moved

The Board's new address is:

Herschler Building East 2nd Floor
122 W 25th St, Cheyenne, WY 82002

If you need to visit with a member of the Board staff in person, we strongly encourage making an appointment by calling the Board office at (307) 634-9636 or by e-mailing bop@wyo.gov

Wyoming State Board of Pharmacy Recognizes Board of Pharmacy Specialties Board Certified Sterile Compounding Pharmacist (BCSCP) Certification Program

On March 18, 2026 the Wyoming State Board of Pharmacy approved the Board of Pharmacy Specialties Board Certified Sterile Compounding Pharmacist (BCSCP) Certification Program as a qualifying certification program under the Wyoming Pharmacy Act Rules, Chapter 8 Wholesale Distributor Regulations, Section 7 Outsourcing Facilities, (e)(iii) which requires outsourcing facilities, also known as 503(b) pharmacies, to ensure "that pharmacists conducting or supervising compounding shall be proficient in the art of compounding and shall acquire the education, training, or experience to maintain that proficiency and become certified by a compounding certification program approved by the Board."

Alerts & Other Information

Twelfth PREP Act Declaration extends
COVID-19 Countermeasures through
December 2029

PREP Act immunity from liability was extended by HHS through through the final day of the applicable Declaration of Emergency, or December 2029 to pharmacists, pharmacy interns, and pharmacy technicians to administer COVID-19 and seasonal influenza vaccines (to those individuals three and over, consistent with other requirements), and COVID-19 tests, regardless of any USG agreement or emergency declaration. For additional information:

REMINDER ALERT

Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition Fraud Alert

The Board's September 2022 newsletter had an article on the Healthcare Distribution Alliance Pharmaceutical Cargo Security Coalition's fraud alert that outlines some new methodologies that are being used to divert both small and large drug shipments. These schemes may involve the impersonation of regulatory personnel, including individuals from state boards of pharmacy and departments of health. They may also involve the impersonation of pharmacy or distributor staff.

Last week a pharmacy in Casper reported being contacted by a scammer posing as the Wyoming Board of Pharmacy, who tried to obtain their wholesale distributor account number. In 2022, a pharmacy in Rock Springs, WY, reported being contacted by a scammer posing as their distributor, who said that they had shipped product to the pharmacy in error and requested that the shipment be returned.

More information is available from the National Association of Boards of Pharmacy®. If you experience an attempt at this type of scam, please email cforsaith@hda.org so that it can be shared with law enforcement.

ALERT Phishing Scam

The Board office has received reports that pharmacists are receiving calls that appear to come from the Board office’s main phone number and that the caller identifies himself or herself as an agent with the Board. The caller is able to confirm some of the pharmacist’s information, such as license number, National Provider Identifier number, and place of employment.

In some cases, the caller accuses the pharmacist of having committed a violation, that his or her license may be suspended or revoked, and that the pharmacist will be arrested if he or she does not answer the caller’s questions. In some cases, the caller alleges that the pharmacist was involved in prescription drug trafficking. Some pharmacists have reported that the caller becomes aggressive and demanding, threatening to have the Federal Bureau of Investigation come and arrest the pharmacist if he or she does not comply.

The Wyoming State Board of Pharmacy will not contact or interact with you in this manner.

The Federal Trade Commission has useful consumer information on how to recognize and avoid phishing scams available at https://www.consumer.ftc.gov/articles/how-recognize-and-avoid-phishing-scams. If you receive such a phone call, please call and report it to the Federal Communications Commission at 888/225- 5322.

DEA Warns Healthcare Workers of Impersonation Scam Targeting Doctors and Pharmacists

The Drug Enforcement Administration (DEA) issued a critical alert to healthcare professionals, warning of recent scam calls targeting doctors and pharmacists. Fraudsters are impersonating DEA agents to steal sensitive information and possibly extort money.

DEA personnel will never contact medical practitioners or members of the public by telephone to request personal or sensitive information, demand money or any other form of payment. Legitimate DEA agents will only notify individuals of investigations or legal actions in person or via official letter.

Reported scam tactics continually change but often share many of the same characteristics. Callers use names found online of well-known DEA officials, retired or former Special Agents, and/or police officers in local departments. Callers will also provide fake badge numbers. Additionally, they may:

use an urgent and aggressive tone.
threaten arrest, prosecution, imprisonment, and, in the case of medical practitioners and pharmacists, revocation of their DEA registration.
reference National Provider Identifier numbers and/or state license numbers when calling a medical practitioner. They also may claim that patients are making accusations against the practitioner.
ask for personal information, such as social security number or date of birth.

Protecting Against Identity Theft

The best deterrence against these bad actors is awareness and caution. Anyone receiving a call from a person claiming to be with DEA should report the incident to the FBI at www.ic3.gov. The Federal Trade Commission provides recovery steps, shares information with more than 3,000 law enforcement agencies and takes reports at reportfraud.ftc.gov.

Reporting these scam calls will help federal authorities find, arrest, and stop the criminals engaged in this fraud. Impersonating a federal agent is a violation of federal law, punishable by up to three years in prison; aggravated identity theft carries a mandatory minimum sentence of two years in prison plus fines and restitution.

The DEA is committed to protecting healthcare professionals from these fraudulent schemes. By raising awareness and encouraging prompt reporting, we can help to stop these criminals and ensure the safety and security of our nation's healthcare workforce.

ALERT Fraudulent Prescription SCAM

The Board has received alerts from pharmacies that an individual or group of individuals are calling in prescriptions for Azithromycin, Ibuprofen, and Promethazine with Codeine. Most of the calls have allegedly come from practitioners in Washington. In some instances, they are asking for particular manufacturers of Promethazine with Codeine, attempting to call multiple sets of prescriptions in at one time, and have requested the pharmacy to ship into another state. The Board urges pharmacists to be cautious and to utilize their professional judgment when exercising their corresponding responsibility and to carefully evaluate such prescriptions for validity before dispensing.

Report abuse